Matt Scantland Net Worth: Career And Wealth In 2026
Matt Scantland Net Worth reflects his success with CoverMyMeds and AndHealth. See available 2026 insights into his career, income sources, and business growth.
Mar 12, 2026818 Shares24.7K Views
Matt Scantland is a native of Columbus, Ohio. He is the son of Alan Scantland and Peg Scantland, and has a twin brother named Pete Scantland. He grew up in the Columbus area, where he and his brother ran small neighborhood businesses delivering newspapers, mowing lawns, and painting house addresses on curbs to earn money.
Even before he could drive, he worked part-time as a bicycle mechanic at a local shop in the Clintonville neighborhood. Scantland later said his first love is building, fixing, and inventing things, starting with bicycles and eventually moving on to cars, motorcycles, and sailboats as he grew up.
Education
Scantland attended The Ohio State University in Columbus. He initially studied engineering but soon switched his major to biological sciences. He graduated from Ohio State with a Bachelor of Science in Biological Sciences, earning honors and distinction. Reflecting on his student years, he noted that he had always demonstrated an aptitude for math and science, but it wasn’t until college that he developed the focus to excel in school.
| Fact | Details |
| Full Name | Matt Scantland |
| Net Worth | Not publicly disclosed (2026) |
| Profession | Tech entrepreneur, healthcare executive |
| Known For | Co-founder of CoverMyMeds |
| Current Role | Founder & CEO of AndHealth |
| Education | Ohio State University graduate |
| Degree | B.S. in Biological Sciences |
| Major Exit | CoverMyMeds sold to McKesson (2017) |
| Company Founded | AndHealth |
| Industry | Digital health technology |
Matt Scantland Career
Matt Scantland is a veteran technology entrepreneur and healthcare executive. He is the founder and chief executive officer of AndHealth, a Columbus, Ohio based digital health company focused on community-centered specialty care for chronic diseases.
Before AndHealth, Scantland co-founded and served as CEO of CoverMyMeds, a healthcare software firm launched in 2008. Under his leadership CoverMyMeds grew into an industry leader in automating medication prior authorizations, reaching thousands of clinicians and pharmacies nationwide.
Scantland guided that company through its acquisition by McKesson Corporation in 2017, a landmark transaction that cemented his reputation as a top healthcare tech entrepreneur.
Entrepreneurial Journey And Early Leadership Roles
After graduating from Ohio State University, Scantland began his career in health IT and quickly returned to startup ventures. He and a pair of colleagues formed Innova Partners, a Columbus based software consulting firm serving healthcare clients.
Through Innova, Scantland learned the industry’s pain points and teamed up with pharmacist Sam Rajan (and, initially, Scantland’s father) in 2008 to launch CoverMyMeds. As co-founder and CEO of CoverMyMeds, Scantland led development of a digital platform that replaced manual prior-authorization paperwork with a streamlined online system.
He oversaw rapid growth and interoperability efforts, integrating with hundreds of electronic health record systems. By the time CoverMyMeds was acquired, it was used by nearly 900,000 health providers and 50,000 pharmacies, handling about 94% of U.S. prescription volume through its prior-auth platform. Scantland remained as CoverMyMeds CEO after the sale, then left in 2019 to pursue new ventures and consulting projects.
Founding AndHealth And Building A Digital Healthcare Company
Scantland founded AndHealth in 2021-2022 to tackle chronic disease management in a new way. He serves as founder and CEO of AndHealth, which set out to “reverse chronic diseases” by engaging patients in their own care.
Under his leadership, the company launched virtual specialty clinics called Virtual Centers of Excellence (VCOEs) for conditions like migraine and autoimmune diseases. These cloud-based care centers connect patients with remote specialists, coaching, and pharmacy services.
Early on, Scantland secured a $57 million financing round for AndHealth in early 2022, backed by Francisco Partners and investors including the American Medical Association’s Health2047 arm. That funding jumpstarted the rollout of AndHealth’s digital platforms, starting with the migraine program and planning subsequent launches for rheumatoid arthritis, psoriasis, and other autoimmune conditions.
Throughout, Scantland has articulated that AndHealth’s strategy is distinct from typical wellness programs it focuses on the highest-priority condition the patient wants to solve and pairs medical care with behavioral support.
Innovation In Community-Based Specialty Care
At AndHealth, Scantland has pioneered an “all-in-one” model that embeds specialty care into community health settings. Rather than relying on hospital or private clinics, AndHealth partners with community health centers (CHCs) to bring specialists, telehealth, and pharmacy services under one roof for underserved patients.
Scantland describes this as a whole-person, community-based care model: patients receive their standard specialty treatment plus personalized coaching and help with social needs (diet, housing, transportation, etc.) at no out-of-pocket cost. The business model is designed so that local clinics can offer these services sustainably and even generate new revenue.
In practice, Scantland’s team has built out-and on-site clinics for migraine and rheumatology within CHCs, supported by health coaches and robust telemedicine tools. This innovative partnership approach addresses access gaps it treats the root causes of disease and patient engagement as priorities.
Scantland emphasizes that by starting with the patient’s most pressing problem (for example, severe migraines) and aligning incentives (through employer and payer programs), his company can achieve high levels of participation and outcomes that traditional care models have not.
Major Achievements, Business Growth, And Industry Recognition
Under Scantland’s leadership, both of his companies have achieved rapid growth and high-profile outcomes. CoverMyMeds became one of Ohio’s first billion-dollar healthcare startups; its acquisition by McKesson in 2017 (approximately $1.4 billion total, including earn-outs) was a record-setting digital health transaction.
At AndHealth, Scantland led the company to close a $57 million growth financing in early 2022, enabling quick national expansion. He attracted marquee investors such as Francisco Partners and the American Medical Association’s innovation arm, signaling confidence in his new venture.
By 2025, AndHealth announced dozens of new hires and an expanded Columbus headquarters to accommodate its scaling operations, adding 75 jobs as part of its nationwide growth plan.
Scantland has also received multiple industry awards for example being named Entrepreneur of the Year by regional business groups and is frequently cited in media and conferences as a leading voice on digital health innovation. His companies have been recognized among the best workplaces in healthcare and tech, reflecting both financial success and strong organizational culture under his guidance.
Current Work, Leadership, And Business Activities
Scantland continues to lead AndHealth as CEO, driving strategic vision and day-to-day execution. He works with a cross-disciplinary executive team (including medical officers, technologists, and finance leaders) to refine AndHealth’s specialty care programs.
In recent years he has overseen pilot programs with major employers and insurers, integrating AndHealth’s app-based programs as employee benefits aimed at reducing chronic disease burdens. He regularly speaks about the company’s model in public forums and publishes thought pieces on the future of healthcare.
In 2025 he announced the firm’s planned expansion in Columbus, Ohio noting that “expanding in Columbus allows us to deepen our commitment to patients and accelerate the delivery of a new healthcare system that can radically expand access” as AndHealth continued hiring and building a national platform.
Today Scantland splits his time between executive duties at AndHealth’s headquarters and meeting with partners across states. He remains focused on forging partnerships with community health centers, hospitals, and technology vendors to scale his model.
Matt Scantland’s Impact And Legacy In Digital Healthcare
Throughout his career, Scantland has combined technical innovation with a patient-centric philosophy. His work with CoverMyMeds fundamentally changed how millions of Americans obtain medications automating a once-manual process that clinicians and payers struggled with and set a new standard for healthcare IT entrepreneurship.
With AndHealth, he is redefining chronic care by treating diseases as reversible through patient engagement and whole-person treatment. His persistent message is that patients must participate in their own care to achieve better health a principle that underpins AndHealth’s programs and broader approach to healthcare innovation.
Scantland’s legacy will likely be seen in both the concrete systems he built (from the CoverMyMeds platform to the AndHealth specialty networks) and the broader shift toward preventive, community-based care he champions.
By demonstrating new business models that align outcomes with incentives and by helping position Columbus as a hub for health tech growth, he has become a recognized leader whose impact spans beyond any single company. His career path from coder to serial CEO underscores a commitment to transforming healthcare through entrepreneurship, and he is widely regarded as a trailblazer in digital health innovation.
Matt Scantland Net Worth
As of 2026, his net worth has not been publicly disclosed, and no figure has been officially verified by major financial authorities. He is the founder and CEO of AndHealth and previously served as the co-founder and CEO of CoverMyMeds; these leadership roles represent his primary sources of income. Specific compensation details (such as salary or equity earnings) from these positions have not been publicly released.
FAQs
Who Is Matt Scantland?
Matt Scantland is an American technology entrepreneur and healthcare executive. He is the founder and CEO of AndHealth, a digital health company focused on improving access to specialty care for chronic diseases.
What Is Matt Scantland Known For?
Matt Scantland is best known as the co-founder and former CEO of CoverMyMeds, a healthcare technology company that automated the prescription prior-authorization process. The company was acquired by McKesson in 2017 in a deal valued at about $1.1–$1.4 billion.
What Company Did Matt Scantland Found After CoverMyMeds?
After leaving CoverMyMeds, Matt Scantland founded AndHealth, a digital healthcare company focused on chronic disease care. The company develops technology-enabled specialty care programs and secured more than $57 million in early funding.
Where Is Matt Scantland From?
Matt Scantland grew up in the Columbus, Ohio area in the United States. His career and entrepreneurial ventures have remained closely connected to the region’s growing health-technology sector.
What Did Matt Scantland Study In College?
Matt Scantland attended The Ohio State University. He initially studied engineering before switching to biological sciences and graduating with a Bachelor of Science degree.
Latest Articles
Popular Articles